Article Text

Download PDFPDF

Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Free

Statistics from Altmetric.com

De Kouchkovsky I, Zhang L, Philip EJ, et al. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer 2021;9:e002127. doi: 10.1136/jitc-2020-002127

This paper has been updated since first published to amend author name ‘Vadim S Koshkin’.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.